The anti-infective viral drugs to witness robust growth as infectious diseases continue to rise amidst changing weather patterns globally.
The anti-infective viral drugs to witness robust growth as infectious diseases continue to rise amidst changing weather patterns globally. The prevalence of diseases like malaria, chikungunya, and chagas disease are also expected to drive demand for anti-infective drugs market in the near future.
According to WHO or the World Health Organization, Vector borne illnesses account for over 700,000 deaths annually. Moreover, these disease account for 17% of all the common infectious diseases. This affects over 3.9 billion people in over 128 countries with spread of illnesses like dengue and nearly a 100 million cases are estimated each year.
Request Brochure of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=41204
Moreover, diseases like malaria have also seen massive global prevention efforts each year. Foundation like the Melinda and Bill Gates foundation has invested large sums of money in preventing diseases like Malaria. This disease causes more than 400,000 deaths each year and the global efforts are expected to drive significant demand for anti-infective viral drugs to counter the threat of the disease.
Moreover diseases like leishmaniasis, chagas disease, and schistosomiasis impact the lives of hundreds of millions each year globally. The spread of these diseases and investments in informed policy making for the prevention of these diseases are expected to drive significant growth for the anti-infective viral drugs market.
Request for Analysis of COVID19 Impact on Anti-infective Drugs Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=41204
Anti-Malaria Drug Sales Jumped 76% in India
Sales of anti-malarial drugs jumped by 76% in Mumbai in 2019. The monsoon season prolonged in the region which led to heavy monsoons and unexpected burden on the healthcare system. The unexpected situation boosted the sales of the pharma industry significantly, which stood at meager 11.2% growth during July to September. It also resulted in 5.5% increase in prices while the volumes rose by 3.2 during the same period. The sales of drugs for vector-borne illnesses was the biggest positive for the market. Moreover, India is proving to be a major success for the prevention of malaria, which has witnessed lowered deaths by about 50% in recent years. The success of the program is likely to drive more growth in the future.
Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=41204
Tropical and Sub-tropical Regions to Drive Growth
Vector-borne illnesses are mostly caused by viruses, parasites, and bacteria. These are often transmitted through sandflies, mosquitoes, blackflies, triatomine bugs, tsetse, lice, mites, snails, and ticks. The suitable climate for growth of various species and changing agricultural practices are leading to an enormous growth of some of these transmitting species and subsequent illnesses. Additionally, factors like rising urbanization, adequate solid waste management, and lacking reliable piped water. Recent outbreaks like Zika virus, prevalence of malaria, and worsening climatic conditions are expected to result in more health precautions, and overwhelm health systems in several nations. The rising initiatives by organizations like WHO to support countries, provide key information for prevention, and innovation in various key anti-infective viral drugs are expected to drive growth.
Buy Anti-infective Drugs Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=41204<ype=S
The review is based on TMR’s report titled “Anti-infective Drugs Market (Type - Anti-bacterial Drugs (B-lactams, Quinolones, Macrolides, Tetracycline, Aminoglycoside, Others (Sulfonamide, Phenicols)), Anti-fungal Drugs (Azoles, Echinocandins, Polyenes), Anti-viral Drugs; Indication - Pneumonia, Methicillin-resistant Staphylococcus Aureus (MRSA), Sepsis, Tuberculosis, Dermatophytosis, Aspergillosis, Candidiasis, Hepatitis Virus Infection, HIV Infection, Respiratory Virus Infection; Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Sales) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017-2025”.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453